Ms Marina Skiba - Researcher Profile

Marina Skiba

Address

Epidemiology & Preventative Medicine
Monash Medical School Building, The Alfred Hospital

Biography

Marina has 25 years experience in clinical research with expertise in protocol development, ethics applications, data management and project co-ordination. She is the Regulatory Affairs Manager for Clinical Pharmacology and provides support to Clinical Pharmacology honours students, PhD students, visiting academics and Registrars.

She is a founding member of the SPHPM Research Governance Committee and chaired the committee from 2010 to 2014. She is also currently an acting Research Governance Office for the school where she co-ordinates the running of the annual self-audit, contributes to Research Governance training within SPHPM and provides support to staff and students in matter of research governance. For further information regarding research governance within the school please see: Research Governance

Marina sits on the Research Review committee which is a sub-committee to the Alfred Hospital Ethics Committee. This committee reviews all high risk projects prior to ethics committee review.

Qualifications

B ED (SEC) SCI
Institution: University of Melbourne
Year awarded: 1991

Publications

Journal Articles

Hopper, I.K., Skiba, M.A., von Lueder, T.G., Watanabe, M., Funston, R., Tonkin, A.M., Krum, H., 2015, Digoxin withdrawal worsens clinical status in stable patients with heart failure receiving optimal contemporaneous therapy -a randomized controlled trial, Journal of Cardiac Failure [P], vol 21, issue 9, Churchill Livingstone, United States, pp. 779-781.

Wu, S., Hopper, I., Skiba, M.A., Krum, H., 2014, Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants, Cardiovascular Therapeutics [P], vol 32, issue 4, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 147-158.

Krum, H., Skiba, M.A., Wu, S., Hopper, I., 2014, Heart failure and dipeptidyl peptidase-4 inhibitors, European Journal of Heart Failure [P], vol 16, issue 6, John Wiley & Sons Ltd., Oxford, United Kingdom, pp. 603-607.

Skiba, M.A., Pick, A., Chaudhuri, K., Bailey, M.J., Krum, H., Kwa, L.J., Rosenfeldt, F.L., 2013, Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol, Heart Lung and Circulation [P], vol 22, issue 8, Elsevier, Australia, pp. 627-633.

Hopper, I., Skiba, M.A., Krum, H., 2013, Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm, European Journal of Heart Failure [P], vol 15, issue 1, Oxford University Press, United Kingdom, pp. 69-78.

Hopper, I., Kemp, W., Porapakkham, P., Sata, Y., Condon, E., Skiba, M., Forber, L., Porapakkham, P., Williams, T., Menahem, S., Roberts, S., Krum, H., 2012, Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography, European Journal of Heart Failure [P], vol 14, issue 6, Oxford University Press, United Kingdom, pp. 621-627.

Hopper, I., Billah, M., Skiba, M., Krum, H., 2011, Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: Meta-analysis of randomised controlled clinical trials, European Journal Of Cardiovascular Prevention & Rehabilitation [P], vol 18, issue 6, SAGE Publications Ltd, UK, pp. 813-823.

Crammond, B., Parker, A., Brooks, M., Skiba, M., McNeil, J., 2011, Self-audit as part of a research governance framework for health research, Medical Journal Of Australia [P], vol 194, issue 6, AMPCo, Australia, pp. 310-312.

Ashton, E., Windebank, E., Skiba, M., Reid, C., Schneider, H., Rosenfeldt, F., Tonkin, A., Krum, H., 2011, Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study, International Journal of Cardiology [P], vol 146, issue 3, Elsevier, Ireland, pp. 404-407.

Brack, J., Sindone, A., Funston, R., Schneider, H., Skiba, M.A., Ueng, K., Krum, H., 2010, Is addition of angiotensin receptor blockade superior to increasing ACE inhibitor dose in patients with heart failure?, International Journal of Cardiology [P], vol 139, issue 3, Elsevier, Ireland, pp. 309-312.

Leet, A., Richardson, M., Senior, J., Funston, R., Skiba, M.A., Bailey, M.J., Krum, H., 2009, A bioavailability study of cyclosporine: comparison of Neoral versus Cysporin in stable heart transplant recipients, Journal of Heart and Lung Transplantation [P], vol 28, issue 9, Elsevier, United States, United Kingdom, France, pp. 894-898.

Szramka, M., Harriss, L.R., Ninio, D., Windebank, E., Brack, J., Skiba, M.A., Krum, H., 2007, The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease, International Journal of Cardiology, vol 117, issue 2, Elsevier Ireland Ltd, Ireland, pp. 287-291.

Poustie, S.J., Taylor, D.M., Forbes, A.B., Skiba, M.A., Nelson, M.R., McNeil, J.J., 2006, Implementing a research governance framework for clinical and public health research, Medical Journal of Australia, vol 185, issue 11-12, Australasian Medical Publishing Co. Pty Ltd, Australia, pp. 623-626.

Krum, H., Skiba, M.A., Gilbert, R.E., 2003, Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy, Diabetic Medicine, vol 20, issue 9, Blackwell Publishing Ltd, UK, pp. 708-712.

Snell, G.I., Kotsimbos, T.C., Levvey, B., Skiba, M.A., Rutherford, D., Kong, D.C.M., Williams, T.J., Krum, H., 2000, Pharmacokinetic assessment of oral ganciclovir in lung transplant recipients with cystic fibrosis, Journal of Antimicrobial Chemotherapy [P], vol 45, issue 4, British Society for Antimicrobial Chemotherapy, UK, pp. 511-516.